Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis

European Respiratory Journal

Volumn 37, Issue 2, 2011, Pages 376-383

  Su, W J ^a,b   Feng, J Y ^a,b   Chiu, Y C ^a   Huang, S F ^a   Lee, Y C ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Culture; Directly observed therapy short course implementation; Mycobacterium tuberculosis; Pulmonary tuberculosis; Sputum

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CAVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; SPUTUM SMEAR; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 79953663702     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00007410     Document Type: Article

References (32)

1. Singla R, Osman MM, Khan N, et al. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 2003; 7: 58-64. (Pubitemid 36427032)
2. Zierski M, Bek E, Long MW, et al. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis 1980; 122: 879-889. (Pubitemid 11207865)
3. Cao JP, Zhang LY, Zhu JQ, et al. Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China. Int J Tuberc Lung Dis 1998; 2: 360-364. (Pubitemid 28239856)
4. Holtz TH, Sternberg M, Kammerer S, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.Ann InternMed 2006; 144: 650-659.
5. Taylor Z, Nolan CM, Blumberg HM, et al. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54: 1-81.
6. Sevim T, Ataç G, Güngör G, et al. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2002; 6: 320-325. (Pubitemid 34263689)
7. Lienhardt C, Manneh K, Bouchier V, et al. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718. (Pubitemid 28429720)
8. Güler M, Unsal E, Dursun B, et al. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007; 61: 231-235.
9. Fortún J, Martín-Dávila P, Molina A, et al. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? J Antimicrob Chemother 2007; 59: 794-798.
10. Salihu HM, Aliyu MH, Ratard R, et al. Characteristics associated with reported sputum culture conversion in the era of re-emergent Mycobacterium tuberculosis in the State of North Carolina, 1993-1998. Int J Tuberc Lung Dis 2003; 7: 1070-1076.
11. Liu Z, Shilkret KL, Ellis HM. Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med 1999; 159: 1110-1116. (Pubitemid 29230864)
12. Domínguez-Castellano A, Muniain MA, Rodriguez-Baño J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7: 432-438. (Pubitemid 36565412)
13. Telzak EE, Fazal BA, Pollard CL, et al. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-670. (Pubitemid 127774281)
14. Abal AT, Jayakrishnan B, Parwer S, et al. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med 2005; 99: 415-420. (Pubitemid 40347824)
15. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169: 1103-1109. (Pubitemid 38624789)
16. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12: 736-743.
17. Glynn JR, Whiteley J, Bifani PJ, et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-849.
18. Van Crevel R, Nelwan RH, de Lenne W, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001; 7: 880-883. (Pubitemid 33121597)
19. Sun YJ, Lim TK, Ong AK, et al. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect Dis 2006; 6: 105.
20. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005; 293: 2726-2731. (Pubitemid 40965084)
21. Feng JY, Su WJ, Tsai CC, et al. Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 2008; 46: 3127-3129.
22. Lan NTN, Lien HTK, Tung LB, et al. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003; 9: 1633-1635. (Pubitemid 37505466)
23. Jou R, Chiang CY, Huang WL. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol 2005; 43: 95-100. (Pubitemid 40096285)
24. Chakravorty S, Dudeja M, Hanif M, et al. Utility of universal sample processing methodology, combining smear microscopy, culture, and PCR, for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2005; 43: 2703-2708. (Pubitemid 40827942)
25. Fodor T. Detection of mycobacteria in sputum smears prepared by cytocentrifugation and sedimentation. Tuber Lung Dis 1995; 76: 273-274.
26. Bruchfeld J, Aderaye G, Palme IB, et al. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg 2000; 94: 677-680.
27. Apers L, Mutsvangwa J, Magwenzi J, et al. A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acidfast bacilli. Int J Tuberc Lung Dis 2003; 7: 376-381. (Pubitemid 36433132)
28. Vidal R, Martin-Casabona N, Juan A, et al. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest 1996; 109: 1562-1565. (Pubitemid 26193385)
29. Lee JS, Kim EC, Joo SI, et al. The incidence and clinical implication of sputum with positive acid-fast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea. J Korean Med Sci 2008; 23: 767-771.
30. Al-Moamary MS, Black W, Bessuille E, et al. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 1999; 116: 726-731. (Pubitemid 29428492)
31. Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J 2005; 26: 339-350. (Pubitemid 41079079)
32. Srisuwanvilai LO, Monkongdee P, Podewils LJ, et al. Performance of the BACTEC MGIT 960 compared with solid media for detection of Mycobacterium in Bangkok, Thailand. Diagn Microbiol Infect Dis 2008; 61: 402-407. (Pubitemid 351982001)